(Q38084093)

28 August 2017

Myocyte enhancer factor 2C in hematopoiesis and leukemia (English)

1 reference

28 August 2017

0 references

1 reference

K Canté-Barrett

1

1 reference

28 August 2017

R Pieters

series ordinal

2

1 reference

28 August 2017

J P P Meijerink

series ordinal

3

1 reference

28 August 2017

language of work or name

English

0 references

publication date

25 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

33

1 reference

28 August 2017

4

1 reference

28 August 2017

403-410

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2013.56

28 August 2017

0 references

cites work

Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Mutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Alternative splicing of Mef2c promoted by Fox-1 during neural differentiation in P19 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Phosphorylation-facilitated sumoylation of MEF2C negatively regulates its transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

MEF2C transcription factor controls chondrocyte hypertrophy and bone development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Mef2c deletion in osteocytes results in increased bone mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

MEF2C enhances dopaminergic neuron differentiation of human embryonic stem cells in a parkinsonian rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Transcription factor MEF2C influences neural stem/progenitor cell differentiation and maturation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Myocyte enhancer factor 2C as a neurogenic and antiapoptotic transcription factor in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

MEF2C haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Refining the phenotype associated with MEF2C point mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The transcription factor MEF2C is required for craniofacial development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Synergistic up-regulation of muscle LIM protein expression in C2C12 and NIH3T3 cells by myogenin and MEF2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The Notch coactivator, MAML1, functions as a novel coactivator for MEF2C-mediated transcription and is required for normal myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Transcriptional mechanisms by the coregulator MAML1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The MADS transcription factor Mef2c is a pivotal modulator of myeloid cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Regulation of lymphoid versus myeloid fate 'choice' by the transcription factor Mef2c

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Regulation of progenitor cell proliferation and granulocyte function by microRNA-223

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Mef2C is a lineage-restricted target of Scl/Tal1 and regulates megakaryopoiesis and B-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

A p38 MAPK-MEF2C pathway regulates B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The calcineurin phosphatase complex modulates immunogenic B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Bone marrow-induced Mef2c deficiency delays B-cell development and alters the expression of key B-cell regulatory proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

HOXA9 is required for survival in human MLL-rearranged acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Cooperative interaction of Nkx2.5 and Mef2c transcription factors during heart development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Cooperative transformation by MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins generated by the variant t(1;19) in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

ETV6 mutations in early immature human T cell leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Competition and collaboration: GATA-3, PU.1, and Notch signaling in early T-cell fate determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Regulation of macrophage and neutrophil cell fates by the PU.1:C/EBPalpha ratio and granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Functional gene expression analysis of tissue-specific isoforms of Mef2c

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

Thymopoiesis independent of common lymphoid progenitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.56

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.56

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference